Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
about
SIRT1 and Kidney FunctionSIRT1: A Novel Target for the Treatment of Muscular DystrophiesMitochondria: a new therapeutic target in chronic kidney diseaseAn Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of ResveratrolSirtuins in epigenetic regulationEmodin suppresses silica-induced lung fibrosis by promoting Sirt1 signaling via direct contactPiceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK SignalingHydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?Sirtuin 1: A Target for Kidney Diseases.The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.CTGF siRNA ameliorates tubular cell apoptosis and tubulointerstitial fibrosis in obstructed mouse kidneys in a Sirt1-independent manner.SIRT3 Blocks Aging-Associated Tissue Fibrosis in Mice by Deacetylating and Activating Glycogen Synthase Kinase 3β.Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars.Reducing Smad3/ATF4 was essential for Sirt1 inhibiting ER stress-induced apoptosis in mice brown adipose tissueThe effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy.Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts.ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease.TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis.Regulation and function of renal medullary cyclooxygenase-2 during high salt loading.SIRT1 reduction is associated with sex-specific dysregulation of renal lipid metabolism and stress responses in offspring by maternal high-fat diet.The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout miceResveratrol ameliorates renal injury in spontaneously hypertensive rats by inhibiting renal micro-inflammation.Network-Based Method for Identifying Co- Regeneration Genes in Bone, Dentin, Nerve and Vessel Tissues.Intestinal flora imbalance promotes alcohol-induced liver fibrosis by the TGFβ/smad signaling pathway in mice.Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes.Resveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1.Impairment of PPARα and the Fatty Acid Oxidation Pathway Aggravates Renal Fibrosis during Aging.Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation.Sirtuins and Accelerated Aging in Scleroderma.Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.Fibrogenic Secretome of Sirtuin 1-Deficient Endothelial Cells: Wnt, Notch and Glycocalyx RheostatAstragaloside IV represses high glucose-induced mesangial cells activation by enhancing autophagy via SIRT1 deacetylation of NF-κB p65 subunitGeniposide Alleviates Isoproterenol-Induced Cardiac Fibrosis Partially via SIRT1 Activation and
P2860
Q26740442-A687F7B5-4577-4CAC-ADEA-764E848960E3Q26748736-FACE9CA3-1489-4F11-80C3-DED31FE2DA65Q26776397-662715D5-560A-4BBD-8C5E-6DC1CE996E59Q26800907-5BD6B478-CC36-46F3-878F-980B4849C254Q27026861-103491E5-42C6-4AB8-8068-5C8F55FCF4FDQ28393597-23056535-DFBF-4C45-9150-BA0DAFFF3477Q28554628-A54CFB11-DC2C-4933-9C78-D38C67C1924BQ35640718-2ECFF0D3-A6D8-49D0-A91F-B5CB9C25BD03Q35707150-6FB3BEA2-E22F-4A00-ADFE-4520DED37089Q35899944-8FF88B60-26DB-4919-A99B-5C871BFDD855Q35923790-BB3B3308-8C44-4DF0-8F89-0F80C8B784A2Q36597265-3C5797B9-56F0-41CE-9A95-8FFE57B620A7Q36830137-ECEE79AF-FDF5-4F91-830C-B82976EBF5EDQ37705953-BEFE27DF-9788-432B-A727-6397350E18BAQ38537368-45A9BD95-A16A-433D-BF5B-CC9381478ABCQ38849140-A639E778-B979-45B8-ACA2-9AF6715F9A4BQ38888431-17A61A6E-4E60-42F6-A043-1815E879018BQ39429579-630E8EF4-46A1-49E6-8978-7136A43DA2CBQ40976804-E9B89F6C-80CC-4AE1-A1BB-BBD3D0A27F95Q41397026-1D100335-6AE7-4183-8073-6197354C4659Q41489153-E8CA04AB-4BE8-400D-8F9F-20B6AF7FD3D6Q41849344-FDB9D2C6-C5FF-4AB8-BE02-08EB74EF32D3Q41857602-74DFF95D-D335-41E4-9A75-94B3DE11C5B4Q44159046-4E21F276-EFF0-4A6E-ACA6-C14C227FA6BCQ47132438-EF0B6C8D-1578-416C-B528-EA4E43474023Q47198646-1304D82B-E9E8-49E4-A794-E104BDA1FDE4Q47700908-F375B6D1-76C7-4075-AE86-830801B65C95Q50027122-A4703CB2-C12A-401E-90F7-E94562B8CC4AQ51735670-0ADAB252-C8C9-48C3-B95C-C9732D5A6BF1Q51762056-1E0418F2-6B3D-449E-AD9A-1FCFF83F9A8FQ53304772-C1E51FFC-B3CD-48ED-9087-9535D9336E70Q57300066-BE3FA63E-3B98-48EE-BBE9-60C9758FD0ECQ58746732-535D60C8-1A8D-4A67-80D2-979826481D42Q58801550-AFBA9F08-D3A4-408F-9CD1-65A80457F4BB
P2860
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
@en
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
@nl
type
label
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
@en
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
@nl
prefLabel
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
@en
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
@nl
P2093
P2860
P356
P1476
Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.
@en
P2093
Chuan-Ming Hao
Donghai Wen
Qionghong Xie
Xin-Zhong Huang
Yueheng Ren
P2860
P304
P356
10.1002/JCB.24748
P577
2014-05-01T00:00:00Z